Reporting of drug reaction with eosinophilia and systemic symptoms from 2002 to 2019 in the US Food and Drug Administration Adverse Event Reporting System.
Reporting of drug reaction with eosinophilia and systemic symptoms from 2002 to 2019 in the US Food and Drug Administration Adverse Event Reporting System.
复制标题
DOI:
10.1016/j.jaip.2021.05.008
复制
发表时间:
2021-08
期刊:
影响因子:
--
通讯作者:
Phillips EJ
中科院分区:
文献类型:
--
作者:
Bluestein SB;Yu R;Stone C Jr;Phillips EJ
登录
查看更多内容
影响因子:
5.6
作者:
Cho YT;Yang CW;Chu CY
通讯作者:
Chu CY
影响因子:
5.6
作者:
Sukasem C;Jantararoungtong T;Kuntawong P;Puangpetch A;Koomdee N;Satapornpong P;Supapsophon P;Klaewsongkram J;Rerkpattanapipat T
通讯作者:
Rerkpattanapipat T
影响因子:
14.2
作者:
Konvinse, Katherine C.;Trubiano, Jason A.;Phillips, Elizabeth J.
通讯作者:
Phillips, Elizabeth J.
影响因子:
14.2
作者:
Phillips, Elizabeth J.;Bigliardi, Paul;Barbaud, Annick
通讯作者:
Barbaud, Annick
DOI:
10.1016/j.jaip.2020.09.021
发表时间:
2021-03
期刊:
The journal of allergy and clinical immunology. In practice
影响因子:
--
作者:
Yu RJ;Krantz MS;Phillips EJ;Stone CA Jr
通讯作者:
Stone CA Jr